Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.

Source:http://linkedlifedata.com/resource/pubmed/id/9482902

Proc. Natl. Acad. Sci. U.S.A. 1998 Mar 3 95 5 2429-34

Download in:

View as

Triples

General Info

PMID
9482902